background: The transcriptome of the endometrium throughout the menstrual cycle has been described in recent years. However, the proteomic of the window of implantation remains unknown. The aim of this study was to compare the proteome of the human endometrium in the pre-receptive phase versus the receptive phase by identifying and quantifying the proteins differentially expressed using differential in-gel electrophoresis (DIGE) and mass spectometry (MS).
Introduction
The endometrium is a specialized hormonally-regulated organ that is non-adhesive to the embryo throughout most of the menstrual cycle in humans and other mammals. In this context, endometrial receptivity is limited to a period in which the endometrial tissue acquires a functional and transient ovarian steroid-dependent status, allowing blastocyst adhesion. The endometrium is receptive to embryonic implantation for a 2-day period [from luteal hormone surge þ 7 (LH þ 7) to luteal hormone þ 9 (LH þ 9) corresponding to days 21-23 of the menstrual cycle], approximately in the mid-secretory phase, and coinciding with the progesterone peak, the so-called 'window of implantation'. The luminal endometrial epithelium acquires a receptive phenotype through specific structural and functional changes. Morphological changes include modifications in the plasma membrane (Murphy, 2004) and cytoskeleton (Martín et al., 2000; Thie and Denker, 2002) . Long thin, regular microvilli gradually convert into irregular, flattened projections in the apical membrane. This process is known as the plasma membrane transformation (Murphy, 2004) . Remodeling the epithelial organization from a polarized to a non-polarized phenotype, might prepare the apical pole for cell-to-cell adhesion (Thie et al., 1995) . These epithelial changes occur simultaneously with the decidualization process in the stromal compartment (Irwin et al., 1989) , starting at the endometrial vasculature.
Recently, major advances in the genomics of endometrial receptivity have been achieved with the availability of microarray and bioinformatics technologies (Horcajadas et al., 2007) , although current proteomic techniques can be used to understand endometrial receptivity at the protein level. DeSouza et al. (2005) employed a semi-quantitative approach to assess the proteomic repertoire of the human endometrial receptivity using Isotope-Coded Affinity Tags, affinity purification and liquid chromatography coupled to mass spectometry (LC-MS) to compare the protein expression between proliferative and secretory endometrium.
To compare the expression profiles of complex protein mixtures, the most widely used method involves protein separation by twodimensional gel electrophoresis (2-DE) based on immobilized pH gradient strips (IPGs) (Gö rg et al., 2005) , followed by protein identification by MS (Aebersold and Mann, 2003) . By resolving complex protein mixtures into protein components, according to their pI and molecular weight (Mw), 2-DE delivers a map of intact proteins that reflects changes in the protein expression levels, isoforms or posttranslational modifications. Nevertheless, 2-DE has limitations like gel-to-gel variability as well as limited sensitivity and dynamic range associated with the detection methods commonly used.
To circumvent these limitations, fluorescence difference in-gel electrophoresis (2D-DIGE) technology (Unlu et al., 1997) provides a more powerful tool to quantify protein expression changes between different conditions. This multiplexed technique is based on the preelectrophoretic labeling of samples with spectrally different fluorescent CyDyes, Cy3 or Cy5, whereas a third spectrally different fluorescent dye, Cy2, is used to label an internal standard sample comprising equal amounts from all the biological samples in the experiment. The use of an internal standard across all the gels allows signal normalization and adequate spot matching, thus enabling both intra-and inter-gel matching (Alban et al., 2003; Knowles et al., 2003) .
To gain insight into the proteomics of endometrial receptivity our aim was to compare the proteome of the pre-receptive versus receptive human endometrium using DIGE and matrix-assisted laser desorption/ionization-mass spectrometry (MALDI-MS) in an attempt to find endometrial proteins which are regulated during the window of implantation.
Materials and Methods

Study design
Human endometrial samples obtained in the pre-receptive (LH þ 2) and receptive (LH þ 7) phases during the same cycle of eight healthy fertile women aged 23 -39 (n ¼ 16) were comparatively investigated by proteomic analysis using DIGE. To avoid a possible bias, samples were labeled using dye-switching, combined in pairs as shown in Table I and analyzed in two experiments (five and three pairs of samples, respectively). Differentially expressed proteins detected by image analysis were identified based on MALDI-MS analysis and validated using western blot. With this approach, two candidate proteins, stathmin 1 and annexin A2 were immunolocalized during the window of implantation. To further test the functional relevance of these molecules, we investigated their expression in an induced endometrial refractoriness model by inserting an intrauterine device (IUD).
Biological samples
This project was approved by the IVI investigation review board. Endometrial samples were obtained after written consent. Endometrial biopsies were taken using pipelle catheters (Genetics, Belgium) under sterile conditions (procedure takes 5 -10 s), and samples were rinsed with PBS and immediately frozen at 2808C until used. Endometrial biopsies (n ¼ 16) at LH þ 2 and LH þ 7 from eight ovum donors were used for proteomic analysis, and six of them (three donors) were validated by western blot and immunohistochemistry. Additionally, another eight endometrial samples (four at LH þ 2 and four at LH þ 7) were taken from eight different donors to confirm the biological significance outside the sample cohort. Three additional fertile cycling women aged 23 -39 were selected for the refractoriness study. Endometrial biopsies were taken at LH þ 7 (receptive endometrium) before IUD insertion, at the time of IUD removal and 3 months after IUD insertion from the same patient (Horcajadas et al., 2006) . A portion of each specimen was histologically examined and dated accordingly (Noyes et al., 1950) .
2D-DIGE sample preparation
Proteins were extracted from endometrial biopsies directly in Lysis Buffer (7 M urea, 2 M thiourea, dimethylammonio)-1-propanesulfonic acid) and 30 mM Tris-pH 8.5) containing 50 mM DTT using the 2D Grinding Kit (GE Healthcare, Chalfont St Giles, UK). The suspension was shaken for 40 min at room temperature and centrifuged at 16 000 Â g for 15 min. Interfering components were removed using the 2D Clean Up Kit (GE Healthcare), and proteins were resuspended in Lysis Buffer. The protein concentration was determined using the RD/DC Protein Assay (Bio-Rad Laboratories, Hercules, CA, USA).
2D-DIGE separation
Proteins were labeled according to the manufacturer (GE Healthcare). Briefly, 50 mg of pre-receptive and receptive endometrial protein extracts were labeled with 400 pmol of the N-hydroxysuccinimide esters of Cy3 or Cy5 fluorescent cyanine dyes on ice in the dark for 30 min. An internal standard, containing equal amounts of each cell lysate, was labeled with Cy2 fluorescent dye and used for all the experiments. The labeling reaction was quenched with 1 ml of 10 mM lysine on ice for 10 min in the dark. The pre-receptive and receptive endometrial protein extracts, and the internal standard protein samples, were combined in pairs as shown 
Endometrial biopsies obtained at LH þ 2 and LH þ 7 from the same women were examined in two separate experiments. Each experiment had its own internal standard. Gels were loaded with paired samples according to the table.
in Table I and run in a single gel (150 mg total proteins). Protein extracts were diluted in Rehydration Buffer (7 M urea, 2 M thiourea, 2% CHAPS), reduced with 50 mM dithiolthreitol (DTT), and applied by cup-loading to 24 cm IPGs pH 3-11NL, which was previously rehydrated with Rehydration Buffer containing 100 mM hydroxyethyl disulfide (DeStreak, GE Healthcare), as described (Cortó n et al., 2004 
Image acquisition and analysis
After sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), gels were scanned with a Typhoon 9400 scanner (GE Healthcare) at 100 mm resolution using appropriate wavelengths and filters for Cy2, Cy3 and Cy5 dyes. Relative protein quantification across LH þ 2 and LH þ 7 samples were performed using DeCyder software v 6.5 and multivariate statistical module Extended Data Analysis (EDA) v1.0 (GE Healthcare) in a stepped process. First, a Differential In-gel Analysis (DIA) module was used to co-detect the three images of a gel (internal standard and two samples) to measure accurate spot ratios of the Cy3 and Cy5 spot volumes referring to the standard Cy2 volume on each gel. Background subtraction, quantification and normalization were automatically applied with low experimental variation (DeCyder Differential Analysis Software User Manual, version 6.5; GE Healthcare, 2005) . Then those images individually processed with the DIA module were matched between gels with the Biological Variation Analysis (BVA) module, using the internal standard for gel-to-gel matching. BVA revealed the differences between experimental groups across all the gels. Each difference was calculated as average ratios for each spot. The paired Student's t test was used to compare average ratios for each spot between LH þ 2 and LH þ 7 subjects. P-values ,0.05 were considered significant. Clustering of the experimental groups was performed by Principal Component Analysis (PCA) using an algorithm included in the EDA module of the DeCyder software v 6.5.
In-gel trypsin digestion
Protein spots showing significantly altered expression levels between the two groups (LH þ 2 and LH þ 7) by DeCyder Differential Analysis Software and EDA were selected for gel excision. Protein spots from silverstained gels were visually matched against DIGE images, manually excised from gels, and transferred to pierced V-bottom 96-well polypropylene microplates (Bruker Daltonik, Bremen, Germany) loaded with ultrapure water. Samples were digested automatically using a Proteineer DP protein digestion station (Bruker Daltonik) according to the protocol of Shevchenko et al. (2006) with minor modifications. Briefly, gel plugs were submitted to reduction with 15 ml of 10 mM DTT (GE Healthcare, Uppsala, Sweden) in 50 mM ammonium bicarbonate (99.5% purity; Sigma Chemical, St. Louis, MO, USA) and alkylation with 15 ml of 55 mM iodoacetamide (Sigma Chemical) in 50 mM ammonium bicarbonate. Gel pieces were then rinsed with 50 mM ammonium bicarbonate and acetonitrile (gradient grade; Merck, Darmstadt, Germany) and dried under a nitrogen stream. Then 10 ml of modified porcine trypsin (sequencing grade; Promega, Madison, WI, USA) at a final concentration of 8 ng/ml in 50 mM ammonium bicarbonate were added to the dry gel pieces, and digestion proceeded at 378C for 8 h. Finally, 6 ml of 0.5% trifluoroacetic acid (TFA) (99.5% purity; Sigma Chemical) were added for peptide extraction, and the resulting digestion solutions were transferred by centrifugation to V-bottom 96-well polypropylene microplates (Greiner Bio-One, Frickenhausen, Germany).
Mass spectrometry
MALDI samples were prepared by mixing equal volumes of the abovementioned digestion solution and a matrix solution composed of 0.5 g/l a-cyano-4-hydroxycinnamic acid (Bruker Daltonik) in 50% aqueous acetonitrile and 0.25% TFA. This mixture was deposited onto a 600 mm AnchorChip prestructured MALDI probe (Bruker Daltonik) (Schürenberg et al., 2000) and allowed to dry at room temperature. Samples were automatically analyzed in an Ultraflex MALDI-TOF/TOF mass spectrometer (Bruker Daltonik) (Suckau et al., 2003) with an automated analysis loop using internal mass calibration, controlled by the flexControl 2.2 software (Bruker Daltonik). In a first step, MALDI-MS spectra were acquired by averaging 300 individual spectra in the positive ion reflector mode at 50 Hz laser frequency in a mass range from 800 to 4000 Da. Internal calibration of MALDI-MS mass spectra was performed using two trypsin autolysis ions with m/z ¼ 842.510 and m/z ¼ 2211.105. In a second step, precursor ions with a signal-to-noise ratio of !20 in the MALDI-MS mass spectrum were subject to fragment ion analysis in the tandem (MS/MS) mode. Precursors were accelerated to 8 kV and selected in a timed ion gate. Fragment ions generated by laser-induced decomposition of the precursor were further accelerated by 19 kV in the LIFT cell, and their masses were analyzed after passing the ion reflector to average 1000 spectra. For MALDI-MS/MS, calibrations were performed with y-ions from fragment ion spectra obtained for the proton adducts of a peptide mixture (peptide calibration standard, Bruker Daltonik) covering the 800 -3200 m/z region. Automated analysis of mass data was performed using the flexAnalysis 2.2 software (Bruker Daltonik). MALDI-MS and MS/MS spectra were manually inspected in detail and reacquired, recalibrated and/or relabeled using the aforementioned programs and homemade software when database searching (see below) was unsuccessful.
Database searching
MALDI-MS and MS/MS data were combined through the BioTools 3.0 program (Bruker Daltonik) to search a non-redundant protein database (NCBInr 20080229, 6 .5 Â 10 6 entries, National Center for Biotechnology Information, Bethesda US) using the Mascot 2.2.1 software (Matrix Science, London, UK; http://www.matrixscience.com) (Perkins et al., 1999) . Other relevant search parameters were set as follows: enzyme, trypsin; fixed modifications, carbamidomethyl (C); allow up to 1 missed cleavage; peptide tolerance +20 ppm; MS/MS tolerance +0.5 Da. Protein scores greater than 80 were considered significant (P , 0.05).
Western blot
Total proteins from endometrial biopsies were extracted as described above. The proteins were denatured for 5 min at 958C, and 80 mg was separated by discontinuous electrophoresis (stacking gel 4% polyacrylamide and resolving gel 10% polyacrylamide) for 1 h at 180 V. Later, proteins were transferred onto the polyvinylidene fluoride (PVDF) membrane by wet electroblotting using Tris/Glycine Transfer Buffer (Biorad). The transfer conditions were 160 V for 4 h at 48C with shaking. Non-fat milk (5%) was used to block the PVDF membrane at room temperature for 1 h. The PVDF membranes were incubated with primary antibodies; 4 mg/ml rabbit monoclonal stathmin 1 (Abcam, Cambridge, UK) and 1 mg/ml annexin A2 goat polyclonal (Affinity BioReagents, Golden, CO) at 48C
overnight. Then membranes were incubated with 1:2000 dilution of polyclonal goat anti-rabbit IgG-HRP (DakoCytomation, CA), and polyclonal rabbit anti-goat IgG-HRP (DakoCytomation, CA) at room temperature for 1 h. PVDF membranes were analyzed with ECL Western Blotting Analysis System (GE Healthcare, Freiburg, Germany) and were photographed using Fujifilm LAS-300, and the subsequent densitometry analysis of bands was done with the Fujifilm Multi Gauge V3.0 program. Membranes were stripped and incubated with a monoclonal mouse antihuman 0.4 mg/ml GAPDH antibody (Abcam, Cambridge, UK) and processed as above.
Immunohistochemistry
Formalin-fixed and paraffin-embedded endometrial biopsies were sectioned and mounted on glass slides coated with Vectabond TM (Vector Lab, Burlingame, CA, USA). Twelve serial sections (5 mm) from each sample were prepared, and the first and last sections were stained with hematoxylin-eosin. After deparaffinization and rehydratation, sections were rinsed three times with phosphate buffered saline (PBS) for 5 min.
Immunohistochemistry was performed on endometrial sections using the LSAB Peroxidase Kit (DAKO, CA, USA). Non-specific binding was blocked with 5% bovine serum albumin (BSA). Sections were incubated for 1 h at room temperature with 6 mg/ml goat polyclonal anti human annexin A2 (Affinity BioReagents, Golden, CO, USA) and 4 mg/ml rabbit monoclonal stathmin 1 (Abcam, Cambridge, UK), both diluted in PBS with BSA 3%. Negative controls in the absence of antibodies were incubated with PBS including BSA 3%. Additional negative and positive control tissues were included for annexin A2 (skin as positive control and testicle as negative control) and stathmin 1 (testicle as positive control and liver as negative control). Secondary antibodies were included in the LSAB Peroxidase Kit (DAKO, CA, USA) valid for rabbit mouse and goat origin primary antibodies. Staining was achieved with 3,3 0 -diaminobenzidine (DAB) chromogen for 30 s to 1 min. After counterstaining with hematoxylin for 10 s and washing with distilled water, slides were mounted with entellan (Merck, Darmstadt Germany).
Results
DIGE analysis of pre-receptive versus receptive endometrium and protein identification by MALDI-MS
We used DIGE-based proteomics to ascertain endometrial receptivity by comparing the protein expression between receptive and prereceptive endometrium. Two independent DIGE experiments were performed based on two distinct sample cohorts. The first experiment comprised 10 samples (five donors), although the second included six additional samples (three donors). To avoid labeling bias arising from the fluorescence properties of gels at different wavelengths, protein extracts were labeled using dye-switching with either Cy3 or Cy5 fluorescent dye. Then each Cy3/Cy5-labeled sample pair was mixed with a Cy2-labeled internal standard onto each gel. After 2-DE, the Cy2, Cy3 and Cy5 channels were individually imaged from each gel. For the multivariate statistical analysis, three out of five gels with higher quality were chosen to prevent reduction of statistical power by removing artefacts in the first experiment. One of the gels was ruled out because it exhibited diminished resolution in the alkaline region, and when it was included in the DeCyder analysis the number of spots present across all gels diminished from ca. 1800 to ca. 600. The other gel was discarded because PCA analysis showed it as a clear outlier corresponding to a sample with a high level of blood contamination (data not shown). All three gels were included in the second experiment. Spot detection with the DIA module (DeCyder TM ) permitted the detection of ca. 2500 spots per gel ( Fig. 1 and Supplementary Figure 1) . These proteins were excised from silver-stained gels, digested in gel with trypsin and identified by MALDI peptide mass fingerprinting and/or peptide fragmentation, followed by a Mascot database search (Table II) . Thirty-two different proteins were identified from the 35 spots which showed significantly different expression levels between the pre-receptive and receptive endometrium: 12 and 23 spots were up-and down-regulated, respectively. Probably due to inter-assay and inter-patient variability the sets of proteins found to be differentially expressed in the two experiments are dissimilar, and only two proteins were found to be consistently deregulated in both experiments: annexin A2 (spots 7, 16 and 33, up-regulated in the receptive endometrium) and stathmin 1 (spots 2, 3 and 20, down-regulated in the receptive endometrium). Moreover, an additional isoform of down-regulated stathmin 1 was found to be phosphorylated at Ser25 in the first experiment, as revealed by a detailed analysis of the MALDI-MS/MS spectrum measured for the parent ion at m/z ¼ 1468.70 from spot 7 (Fig. 2) .
Validation of DIGE results by western blot
To validate protein differences attained by DIGE, western blot was first performed for annexin A2 and stathmin 1 in 6 out of 12 samples used in the DIGE experiment (three donors). The results obtained in the western blot bands followed a similar regulation to DIGE analysis (Fig. 3A) . We analyzed eight additional natural cycle endometrial biopsies from different women to ensure this up-and down-regulation outside the sample cohort (Fig. 3B) . GAPDH was used as a control to normalize protein abundance in all the experiments.
Immunolocalization of stathmin 1 and annexin 2 in the receptive and pre-receptive endometrium
Since annexin A2 and stathmin 1 are apparently important for the reorganization of the cytoskeleton, and are the proteins found in both DIGE experiments, we decided to localize these proteins in the human endometrium at the LH þ 2 (pre-receptive) and LH þ 7 (receptive) phases. Annexin A2 showed a slight staining in the prereceptive endometrium, and was restricted to some stromal cells and apical endometrial glands (Fig. 4A) , although staining in the receptive phase was strongly present in endometrial glands (Fig. 4B) . Stathmin 1 followed the opposite trend, as this protein was mainly localized in the stromal cells and the apical surface of the endometrial glands with a stronger intensity in the pre-receptive (Fig. 4E ) compared with the receptive endometrium (Fig. 4F) .
Functional relevance of stathmin 1 and annexin 2 in a human model of endometrial refractoriness
To test the functional relevance of stathmin 1 and annexin 2, endometrial refractoriness was induced by inserting an IUD. Three endometrial samples from three different patients (n ¼ 9) obtained at LH þ 7 were analyzed by immunohistochemistry: the previous IUD insertion cycle, the time of IUD removal and 3 months later. Our results demonstrated that annexin A2 was strongly expressed in endometrial glands and stromal cells before IUD insertion (Fig. 4I ), which agrees with the findings in the receptive endometrium. When inserting an IUD into the endometrium, the glandular staining was reduced, although it was completely absent in the stroma (Fig. 4J) . Three months after IUD removal, the immunolocalization of annexin A2 was similar to that before IUD insertion in the same woman (Fig. 4K) .
Before IUD insertion, stathmin 1 also displayed the same pattern already described in the receptive endometrium (LH þ 7), with a faint staining in endometrial glands (Fig. 4L) . However, when an IUD was present, the staining in the stroma and endometrial glands increased similarly to the pre-receptive stage (Fig. 4M) , and three months after IUD removal the endometrium regained the receptive stathmin 1 pattern (Fig. 4N ). In the induced refractory endometrium, the indicated dysregulation in the immunoreactive staining pattern of both proteins identified in this study strongly suggests their functional implication in endometrial receptivity.
Discussion
The scientific knowledge of the endometrial receptivity process is fundamental for the understanding of the mechanisms that govern embryonic implantation and human reproduction. It can potentially be used to improve fertility in infertile patients, whereas the opposite can be applied as an interceptive approach to prevent embryo implantation (Simó n et al., 1992).
An initial attempt to identify different protein markers between proliferative and secretory endometrium was published by DeSouza et al. (2005) based on LC-MS. Two of the proteins reported were glutamate NMDA receptor subunit zeta 1 precursor and FRAT1. These proteins were not detected in our study, probably due to the different nature of the samples analyzed (proliferative phase (n ¼ 3) and secretory endometrium (n ¼ 3) versus LH þ 2 (n ¼ 8) and LH þ 7 (n ¼ 8) in our study), and to the different techniques used in both studies.
In our study, the differently expressed spots revealed by DIGE analysis were subject to protein identification based on in-gel digestion, MALDI-MS and Mascot database searching. We compared our list of Individual proteins of endometrial LH þ 7, LH þ 2 samples and a pooled internal standard were labeled with CyDyes Cy3, Cy5 and Cy2, respectively, and were mixed and separated on a 2D gel using 24 cm pH3-11NL (left to right) strips in the first dimension and 10% PAGE-SDS gels in the second dimension. Gels were scanned to obtain single images of LH þ 7 proteins (Cy3, green) (A), LH þ 2 proteins (Cy5, red) (B) or the internal standard (Cy2, not shown). An overlay of the two dyes (Cy3, Cy5) (C) is shown (Merge). The same gel, after fluorescence imaging, was silver-stained and scanned (Silver) Although some up-or down-regulated proteins in our study matched their gene expression pattern, such as stathmin 1, annexin A2, monoamine oxidase A, membrane-associated progesterone receptor component 1, tropomyosin-alpha 3, collagen alpha 1, annexin A4 and protein S100-A10 (Riesewijk et al., 2003; Mirkin et al., 2005) , many other gene expression profiles in our and other's transcriptomic studies do not correlate to protein abundance. It is well known that altered gene expression not always correlates with changes in protein abundance (Chen et al., 2002) . In addition, post-transcriptional modifications could further contribute to this imbalance. Obviously, no single approach can fully unravel the complexities of fundamental biology and it is also apparent that integrative analysis of multiple levels of gene expression would be valuable in this endeavor (Nie et al., 2006) . Integrated analysis of global scale transcriptomic and proteomic data can provide important insights into the metabolic mechanisms underlying complex biological systems like endometrial receptiveness and implantation. However, because the relationship between protein abundance and mRNA expression level is complicated by many cellular and physiological processes, sophisticated statistical models would be needed to capture their relationship. On the other hand, transcriptomic studies on endometrial receptiveness have resulted in a large number of altered genes as compared with the limited number of altered proteins revealed in this proteomic study. This can be explained by limitations related to the 2-DE technique which preclude the analysis of proteins outside the pH range (3-11) of the strip used, along with very large or small species and hydrophobic or low-abundant proteins. In addition, most secreted proteins are not present in the endometrial biopsies. Interestingly, stathmin 1 and annexin A2, two cytoskeleton-related proteins, display a consistent opposite regulation in the receptive versus pre-receptive endometrium, and appear to be dysregulated in the refractory endometrium induced by IUD insertion. This is not surprising since the endometrial receptive phenotype is associated with a remodeling of the epithelial organization, primarily as a result of the disruption of the cytoskeleton in response to externals signals. These changes are due to the destabilization of the apico-basal polarity of the endometrial epithelium, and prepare the apical pole for cell-to-cell adhesion (Martín et al., 2000) .
Stathmin 1, also known as Op18 or p19, is a highly conserved 19 kDa phosphoprotein that has four serine residues at its N-terminus (Irwin et al., 1989; Thie et al., 1995) and acts as a regulator of microtubule dynamics during cell-cycle progression. Some evidence suggests that stathmin 1 promotes microtubule disassembly (Larsson et al., 1997) by increasing the microtubule turnover for the reorganization of the cytoskeleton. The phosphorylation of stathmin 1 by different kinases has been shown to deactivate its microtubule destabilizing activity, which in turn, promotes polymerization.
Stathmin 1 levels have been described to specifically regulate at the embryo implantation site, and to be down-regulated as decidualization progresses in rodents (Tamura et al., 2003; Yoshie et al., 2004) . Tamura et al. demonstrated that stathmin 1 is associated with the proliferation and/or differentiation of endometrial cells during pregnancy in humans. When stromal cells were decidualized, stathmin 1 levels decreased, and when its expression was interfered by RNAi, a Spot numbering as shown in 2-DE silver gel in Fig. 1 (spots 1-18 (Fig. 2) . decidualization was suppressed (Tamura et al., 2006) . Our results indicate that stathmin 1 is down-regulated in the receptive endometrium, which supports the hypothesis that lower levels of this molecule promote or support decidualization, although high levels of stathmin 1 (proliferative phase) increase stromal proliferation, as shown in other cell types (Rowlands et al., 1995) . Given the high content of stromal cells in the endometrium and the massive decidualization process, the down-regulation of stathmin 1 in the receptive endometrium is not striking. Phosphorylation of stathmin 1 could regulate the quantity of active protein present in the stroma, creating a gradient of phosphorylated/dephosphorylated protein. In particular, phosphorylation at Ser16 and Ser63 down-regulates the microtubule destabilizing activity of stathmin 1, and phosphorylation at multiple sites is necessary for stathmin 1 to progress in the cell cycle (Rubin and Atweh, 2004) . In fact, one of the decreased stathmin 1 proteins detected in the receptive endometrium was phosphorylated at least at Ser25, suggesting a more complex system that requires further research.
Moreover, we showed that the expression pattern of stathmin 1 in a refractory endometrium (IUD) is completely reversed, presenting an intense staining in the stroma which according to the indicated mechanism may inhibit decidualization and, therefore, interfere with the invasion process.
Previous studies suggested that stathmin is involved in the proliferation of human endometrial cells to promote microtubule destabilization and allow the formation of new networks (Tamura et al., 2006) . We hypothesize that this protein is implicated in the proliferation of stroma cells (up-regulated in pre-receptive endometrium) that constitute the functional layer of the endometrium and prepare it for The precursor ion at m/z ¼ 1468.70 was selected from the MS spectrum corresponding to spot 7 for ion fragment analysis. Ions ascribed to the main fragmentation series, y (C-terminal series) and b (N-terminal series), have been labeled, and the sequence match is displayed. Fragment ions corresponding to the neutral loss of H 3 PO 4 (298 atomic mass units) from the phosphorylated serine are denoted by '-P', and identified internal fragments are labeled with their amino acid sequence. Additional neutral losses are also indicated. For clarity, ion intensity in the 50 -950 m/z region was magnified eight times. implantation. Afterwards stathmin decreased to proceed with the decidualization process, as several studies have shown.
The annexin A2 heterotetramer consists in two copies of annexin A2 and two copies of S100A10/p11. It promotes fibrinolytic activity on the surface of vascular endothelial cells by assembling plasminogen and tissue plasminogen activator, and by accelerating the generation of plasmin (Kwon et al., 2005) . It has also been implicated in the regulation of different cellular functions, including secretory processes, prolactin release and prostaglandin formation (Kwon et al., 2005) . The cellular distribution of these proteins has been examined in human term placenta, fetal membranes (amnion and chorion laeve) and decidua using immunohistochemistry (Sun et al., 1996) . Annexin A2 was located in the amnion epithelial cells, the cells of the mesenchymal layer, among the amnion and chorion, trophoblast and endothelial cells lining of the blood vessels in the decidua. Annexin A2 was located in the villous core and not in the syncytiotrophoblast cells in the placenta. Moreover, Fowler et al. (2007) identified several dysregulated proteins by proteomics techniques in women with endometriosis, which included annexin A2. The crosslinking of annexin A2 on the endothelial cell surface has also been described to induce the expression of cell adhesion molecules (Wolberg and Roubey, 2005) .
In our study, annexin A2 (in both experiments) and S100A10 (in one experiment) were found up-regulated in the receptive endometrium (Table II) , highlighting the importance of this active heterotetramer in the receptive endometrium that could allow the adhesion of the embryo. In our IUD study, annexin A2 diminished dramatically in the epithelial cells and is absent in stroma cells when an IUD is present, suggesting a lack of functional annexin A2 in the refractory endometrium. Annexin A2 has been shown to play an essential role in maintaining the dynamic of membrane-associated actin cytoskeleton (Hayes et al., 2006) . Recent published data have identified annexin A2 as a major insulin receptor substrate that is directly linked with actin rearrangements and cell adhesion (Rescher et al., 2008) . We postulate Figure 4 Immunohistochemistry of stathmin 1 and annexin A2 in the pre-receptive, receptive and refractory human endometrium.
(A-D). Immunoreactive annexin A2 in pre-receptive (LH þ 2) and receptive (LH þ 7) human endometrium (A, B), skin (C) and testicle (D). Faint staining is observed in the stromal and glandular epithelium in the pre-receptive endometrium (A), although clear stronger staining is observed throughout the tissue in the receptive endometrium (B). Strong staining is detected in the epidermis (positive control) (C). No signal was observed in the human testicle (D). (E -H) Immunoreactive stathmin 1 in pre-receptive (LH þ 2) (E) and receptive (LH þ 7) (F) human endometrium, testicle (G) and liver (H). Strong staining is present in stromal cells and in the apical part of the glandular epithelium in the pre-receptive endometrium (E), although the signal is practically absent in stromal cells, and some patches of faint staining are observed in endothelial and epithelial glandular cells in the receptive endometrium (F). Clear staining is observed in the human testicle (positive control) (G). No signal was observed in the human liver (H). (I -K) Expression of annexin A2 in the receptive endometrium (LH þ 7) before (I), during (J) and after (K) the presence of an IUD in the endometrium. As indicated, annexin A2 staining was the strongest in the receptive endometrium before IUD insertion, but when an IUD was present, staining decreases and was restricted to the glandular epithelium. Three months after IUD removal, staining is still low in all locations. (L -N) The expression of stathmin 1 in the receptive endometrium (LH þ 7) before (L), during (M) and after (N) the presence of an IUD. The signal from stathmin 1 is faint in the receptive endometrium, as confirmed above (L). When an IUD was present in the uterus, stathmin 1 staining increased considerably in the glandular epithelium and stromal cells (M). Three months after IUD removal, again the signal from stathmin 1 was faint in the stromal cells, but there was still a strong signal in the glandular epithelium.
that the up-regulation of annexin A2 in the receptive endometrium could be important for the changes to prepare the apical pole for cell-to-cell adhesion. Consequently, both annexin A2 and stathmin 1 could be possible interception targets, but further research is needed to test our hypothesis.
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